![]() | |
Clinical data | |
---|---|
Routes of administration | Oral |
Drug class | Orexin 1 receptor antagonist |
Identifiers | |
| |
PubChem CID | |
ChemSpider | |
ChEMBL | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C31H38N2O5 |
Molar mass | 518.654 g·mol−1 |
3D model (JSmol) | |
| |
|
ACT-335827 is an orally available, selective orexin 1 receptor antagonist with anxiolytic effects in animals. Unlike other orexin receptor antagonists, ACT-335827 lacks sedative effects and was found to have no impact on sleep architecture in mice.[1][2]
| |
---|---|
OX1 |
|
OX2 |
|
![]() | This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it. |